UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037371
Receipt number R000042610
Scientific Title Collaborative research on the efficacy and safety of laparoscopic sacrocolpopexy (Japanese LSC) with the same technique in Japan
Date of disclosure of the study information 2019/07/16
Last modified on 2023/07/18 15:03:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Collaborative research on the efficacy and safety of laparoscopic sacrocolpopexy (Japanese LSC) with the same technique in Japan

Acronym

Collaborative research on the efficacy and safety of laparoscopic sacrocolpopexy (Japanese LSC) with the same technique in Japan

Scientific Title

Collaborative research on the efficacy and safety of laparoscopic sacrocolpopexy (Japanese LSC) with the same technique in Japan

Scientific Title:Acronym

Collaborative research on the efficacy and safety of laparoscopic sacrocolpopexy (Japanese LSC) with the same technique in Japan

Region

Japan


Condition

Condition

Pelvic Organ Prolapse

Classification by specialty

Obstetrics and Gynecology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will investigate the efficacy and safety of the Japanese-made LSC, which is an advanced version of the French LSC by the double mesh method in Japan, in a multicenter study.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1 Anatomical effectiveness with the POP-Q system.
2 Safety evaluation using Clavien-Dindo classification, Prosthesis / Graft Complication Classification Code.
3 Subjective effectiveness using P-QOL

Key secondary outcomes

1 Effects on lower urinary tract symptoms using IPSS
2 Effects on urinary incontinence using ICIQ-SF
3 Effects on OABSS overactive bladder
4 Effects on defecation function using PFDI
5 Effects on sexual function using PISQ-IR


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Among patients scheduled to receive treatment according to the same procedure (Japanese LSC) for pelvic organ prolapse, those who could obtain consent for the survey

Key exclusion criteria

Patients who did not obtain consent for this study, patients who underwent concurrent surgery for co-morbidities.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Masami
Middle name
Last name Takeyama

Organization

First Towakai Hospital

Division name

Femaleurology, urogynecologycenter

Zip code

569-0081

Address

2-17, Miyano-cho, Takatsuk city

TEL

072-671-1008

Email

m-takeyama@me-medical.jp


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Kuwata

Organization

First Towakai Hospital

Division name

Femaleurology, urogynecologycenter

Zip code

569-0081

Address

2-17, Miyano-cho, Takatsuk city

TEL

072-671-1008

Homepage URL


Email

kuwatomo1108@gmail.com


Sponsor or person

Institute

First Towakai Hospital

Institute

Department

Personal name



Funding Source

Organization

First Towakai Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

First Towakai Hospital

Address

2-17, Miyano-cho, Takatsuk city

Tel

072-671-1008

Email

kuwatomo1108@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

152

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 03 Month 05 Day

Date of IRB

2018 Year 03 Month 26 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will monitor postoperative recurrence and complications, quality of life, etc.


Management information

Registered date

2019 Year 07 Month 14 Day

Last modified on

2023 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042610


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name